Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy
Launched by YALE UNIVERSITY · Feb 18, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to help people recover from stroke-related issues, like pain and problems moving one hand. One group of participants will receive traditional mirror therapy, where they use a mirror to help their brain reconnect with the affected hand. The other group will use a special device called the Miraπ, which moves the affected limb for them while they follow along with the movements. This study aims to see if using the Miraπ device is more effective than the standard mirror therapy.
To join the trial, participants need to be between 65 and 74 years old and have been approved for rehabilitation after their stroke. They should have difficulties using one hand but be able to understand simple instructions, like moving their healthy fingers. Participants will receive care from their regular rehabilitation team, and they will be closely monitored throughout the trial. It's important to note that those with certain conditions, such as severe spasticity (muscle stiffness) in the affected hand or those who are not physically cleared for rehab, cannot take part in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants currently accepted and cleared for rehabilitation in the inpatient rehabilitation unit by the rehabilitation medical director.
- • Participants with paralysis or motor function problems of only one hand.
- • Participants need mirror therapy because of their health condition.
- • Participants' rehabilitation physician determined that mirror therapy would be appropriate for standard of care.
- • Participants are able to memorize easy tasks, and able to follow instructions e.g., moving the healthy fingers.
- Exclusion Criteria:
- • Participants who are not cleared physically or medically to participate in standard acute inpatient rehabilitation therapies by the rehabilitation medical director
- • Participants who are not able to memorize easy tasks, e.g., moving the healthy fingers.
- • Participants with spasticity of the affected hand (as assed by the occupational therapist)
- • Minors
- • Vulnerable populations
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milford, Connecticut, United States
Patients applied
Trial Officials
Necolle Morgado-Vega
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported